Vidarabine Monophosphate

单磷酸阿糖腺苷

Report date: 2023/02/15 15:56:56
NME

Base Information

Drug NameVidarabine Monophosphate
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCytomegalovirus InfectionsHerpesviridae Infections
Global Approved IndicationsCytomegalovirus InfectionsHerpesviridae Infections
Approved Indications in ChinaCytomegalovirus InfectionsHerpesviridae Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Longfu Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsCytomegalovirus InfectionsHerpesviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A